2Ter maaten JC, Franssen CFM, Gans ROB, et al. Respiratory failure in ANCA-associated vasculitis [J]. Chest,1996,110 : 357-362.
3Ludemann J. New aspects of human polymorphonuclear leukocytes[J]. New York and London Plenum Prers,1993,141-150.
4Gilligan HM, Bredy B, Brady HR, et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming[J]. J Exp Med, 1996,184:2231-2241.
5Yang JJ, Tuttle RH, Hogan JG, et al. Target antigens for antineutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils[J]. Clin Exp Immunol, 2000,121:165-172.
6Sibelius U, Hattar K, Schenkel A, et al. Wegner′s granulo-matosis anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response [J]. J ExpMed,1998,187:497-503.
7Harrison P,sayegh H, Ohara Y, et al. Regulation of expression of the endothelial nitric oxide synthase[J]. Clin Exp Pharmacol Phys, 1996,23: 251-255.
8Heeringa P, Van-Goor H, Klok P, et al. Expression of iNOS, eNOS and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associted crescentic glomerulonephritis[J]. Kidney Int, 1998,53: 382-393.
9Franssen CFM, Huttema MG, Muller-Kobold AC, et al.In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis[J]. J Am Soc Nephrol, 1999,10:1506-1515.
10Pauzner R, Urowitz M, Gladman D, et al. Antineutrophil Cytoplasmic antibodies in systemic lupus erythematosus [J]. J Rheumatol, 1994,21:1670.
